| 000 | 01337 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250514021536.0 | ||
| 264 | 0 | _c20020307 | |
| 008 | 200203s 0 0 eng d | ||
| 022 | _a0027-8874 | ||
| 024 | 7 |
_a10.1093/jnci/94.1.32 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchildkraut, Joellen M | |
| 245 | 0 | 0 |
_aImpact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk. _h[electronic resource] |
| 260 |
_bJournal of the National Cancer Institute _cJan 2002 |
||
| 300 |
_a32-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aContraceptives, Oral, Hormonal _xpharmacology |
| 650 | 0 | 4 |
_aEstrogens _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xepidemiology |
| 650 | 0 | 4 |
_aProgestins _xadministration & dosage |
| 650 | 0 | 4 | _aRisk |
| 700 | 1 | _aCalingaert, Brian | |
| 700 | 1 | _aMarchbanks, Polly A | |
| 700 | 1 | _aMoorman, Patricia G | |
| 700 | 1 | _aRodriguez, Gustavo C | |
| 773 | 0 |
_tJournal of the National Cancer Institute _gvol. 94 _gno. 1 _gp. 32-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/94.1.32 _zAvailable from publisher's website |
| 999 |
_c11685246 _d11685246 |
||